Chapter 1 - Remdesivir

This is a listing of all citations in this chapter.

31

Matt Krantz, “Bill Gates’ Coronavirus Manifesto Reveals 5 Forecasts For Investors,” Investor’s Business Daily (Apr. 24, 2020, 01:48 PM ET).

32

Associated Press, “Fauci calls Henry Ford study on hydroxychloroquine and COVID-19 ‘flawed’,” (Jul. 31, 2020).

33

CNBC, “Dr. Anthony Fauci: No placebo-controlled trial has shown hydroxychloroquine is effective,” (Jul. 31, 2020).

34

CNN, “Dr. Fauci warns against taking Ivermectin to fight Covid-19,” (Aug. 29, 2021).

35

Jason D. Goldman, et al., “Remdesivir for 5 or 10 Days in Patients with Severe Covid-19,” NEJM (May 27, 2020).

36

European Medicines Assessment Report: Veklury, European Medicines Agency (Jun. 25, 2020).

37

NIAID, “A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults,” NIH Clinical Trials.GOV (Apr. 2, 2020).

38

John H. Beigel, M.D., et al., “Remdesivir for the Treatment of Covid-19 — Final Report,” N Engl J Med 383 (Nov. 5, 2020):1813-1826, doi: 10.1056/NEJMoa2007764.

39

Health News Review, “Primary Outcome Measures: Screenshot of ClinicalTrials.gov,” Health NewsReview (Apr. 30, 2020, 3:18 PM).

Screenshot from article

40

COVID-19 Treatment Guidelines Panel Members, (Last Updated: August 4, 2021).

41

Jon Cohen, “Quarantined at home now, U.S. scientist describes his visit to China’s hot zone,” Science (Mar. 6, 2020).

42

COVID-19 Treatment Guidelines Panel, Coronavirus Disease 2019 (COVID-19) Treatment Guidelines, National Institutes of Health.

43

AHRP, “Brazilian Scientists Speak Out Against Corrupted “Science” & the Use of Inhumane Study Methods,” AHRP (May 27, 2020).

44

AHRP, “Dissolving Illusions–“Authoritative” Medical Information Sources Are Corrupted,” AHRP (Nov. 26, 2017).

45

AHRP, “Nobody Should Volunteer for Clinical Trials As Long As Research Data Is Secret,” AHRP (Apr. 12, 2012).

46

AHRP, “Medical Journals Complicit in Corruption of Medicine,” AHRP (Nov. 13, 2010).

47

AHRP, “BMJ Demands Raw Data From Pharma Clinical Trials,” AHRP (Dec. 10, 2009).

48

Yeming Wang, MD, et al., “Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial,” Lancet 395 no. 10236 (May 16, 2020):1569-1578.

49

Yeming Wang, MD, et al., “Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial,” Lancet 395 no. 10236 (May 16, 2020):1569-1578.

50

Phil Taylor, “Gilead slides as second Chinese trial of remdesivir is stopped,” Pharmaphorum (Apr. 15, 2020).

51

Erika Edwards, “Remdesivir shows promising results for coronavirus, Fauci says,” NBC (Apr. 29, 2020).

52

Gina Kolata, Peter Baker and Noah Weiland, “Remdesivir Shows Modest Benefits in Coronavirus Trial,” New York Times (Apr. 29, 2020, Updated Oct. 29, 2020).

53

FDA, “EUA Letter of Approval Veklury (remdesivir),” RADM Denise M. Hinton-FDA (May 1, 2020, revised Oct. 22, 2020).

54

Veklury (remdesivir), “Information for US Healthcare Professionals.”

55

Sarah Boseley, “US secures world stock of key Covid-19 drug remdesivir,” The Guardian (Jun. 30, 2020).

56

Francesco Guarascio, “EU makes 1 billion-euro bet on Gilead’s COVID drug before trial results,” Reuters (Oct. 13, 2020).

57

Gillings School News, “Remdesivir, developed through a UNC-Chapel Hill partnership, proves effective against COVID-19 in NIAID human clinical trials,” UNC Gillings School of Global Public Health (Apr. 29, 2020).

58

Gillings School News, “Remdesivir, developed through a UNC-Chapel Hill partnership, proves effective against COVID-19 in NIAID human clinical trials,” UNC Gillings School of Global Public Health (Apr. 29, 2020).

59

AHRP, “Fauci’s Promotional Hype Catapults Gilead’s Remdesivir,” AHRP (May 6, 2020).

60

Public Citizen, “The Public Already Has Paid for Remdesivir,” Public Citizen (May 7, 2020).